glp 1 direct A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders While some have noticed positive changes in their appetite and energy levels Antiatherosclerotic potential of GLP-1 action.

doi: 10.5603/EP.A2022.0030

Caturano, A

Melanotan 2 is a synthetic peptide (a-MSH) and interacts with the melanocortin receptors throughout our body, stimulating physiological responses

Grssel, S

Image Credit: Anna Hoychuk/Shutterstock.com Ozempic functions primarily by enhancing insulin secretion, suppressing glucagon release, and reducing appetite, mechanisms distinctly tied to GLP-1 receptor activation

Access this article Similar content being viewed by others Abbreviations AHI: apnea-hypopnea index BMI: body mass index CPAP: continuous positive airway pressure ESS: Epworth Sleepiness Scale GIP/GLP-1 receptor agonists: dual gastric inhibitory polypeptide/glucagon-like peptide-1 receptor agonists GLP-1 receptor agonists: glucagon-like peptide-1 receptor agonists ODI: oxygen desaturation index OSA: obstructive sleep apnea SGLT2 inhibitors: sodium-glucose cotransporter-2 inhibitors T2DM: type 2 diabetes mellitus REFERENCES Osman AM, Carter SG, Carberry JC, et al